Your browser doesn't support javascript.
loading
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Ewer, Katie J; Barrett, Jordan R; Belij-Rammerstorfer, Sandra; Sharpe, Hannah; Makinson, Rebecca; Morter, Richard; Flaxman, Amy; Wright, Daniel; Bellamy, Duncan; Bittaye, Mustapha; Dold, Christina; Provine, Nicholas M; Aboagye, Jeremy; Fowler, Jamie; Silk, Sarah E; Alderson, Jennifer; Aley, Parvinder K; Angus, Brian; Berrie, Eleanor; Bibi, Sagida; Cicconi, Paola; Clutterbuck, Elizabeth A; Chelysheva, Irina; Folegatti, Pedro M; Fuskova, Michelle; Green, Catherine M; Jenkin, Daniel; Kerridge, Simon; Lawrie, Alison; Minassian, Angela M; Moore, Maria; Mujadidi, Yama; Plested, Emma; Poulton, Ian; Ramasamy, Maheshi N; Robinson, Hannah; Song, Rinn; Snape, Matthew D; Tarrant, Richard; Voysey, Merryn; Watson, Marion E E; Douglas, Alexander D; Hill, Adrian V S; Gilbert, Sarah C; Pollard, Andrew J; Lambe, Teresa.
Affiliation
  • Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK. katie.ewer@ndm.ox.ac.uk.
  • Barrett JR; The Jenner Institute, University of Oxford, Oxford, UK.
  • Belij-Rammerstorfer S; The Jenner Institute, University of Oxford, Oxford, UK.
  • Sharpe H; The Jenner Institute, University of Oxford, Oxford, UK.
  • Makinson R; The Jenner Institute, University of Oxford, Oxford, UK.
  • Morter R; The Jenner Institute, University of Oxford, Oxford, UK.
  • Flaxman A; The Jenner Institute, University of Oxford, Oxford, UK.
  • Wright D; The Jenner Institute, University of Oxford, Oxford, UK.
  • Bellamy D; The Jenner Institute, University of Oxford, Oxford, UK.
  • Bittaye M; The Jenner Institute, University of Oxford, Oxford, UK.
  • Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Provine NM; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Aboagye J; The Jenner Institute, University of Oxford, Oxford, UK.
  • Fowler J; The Jenner Institute, University of Oxford, Oxford, UK.
  • Silk SE; The Jenner Institute, University of Oxford, Oxford, UK.
  • Alderson J; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Berrie E; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Cicconi P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Chelysheva I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK.
  • Fuskova M; The Jenner Institute, University of Oxford, Oxford, UK.
  • Green CM; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK.
  • Kerridge S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK.
  • Minassian AM; The Jenner Institute, University of Oxford, Oxford, UK.
  • Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Poulton I; The Jenner Institute, University of Oxford, Oxford, UK.
  • Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Tarrant R; Clinical Biomanufacturing Facility, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Watson MEE; The Jenner Institute, University of Oxford, Oxford, UK.
  • Douglas AD; The Jenner Institute, University of Oxford, Oxford, UK.
  • Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK.
  • Gilbert SC; The Jenner Institute, University of Oxford, Oxford, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Lambe T; The Jenner Institute, University of Oxford, Oxford, UK. Teresa.lambe@ndm.ox.ac.uk.
Nat Med ; 27(6): 1116, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34021278
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2021 Document type: Article Affiliation country: